About
About Me
Multidisciplinary Scientist-Entrepreneur
Accomplished biotechnology scientist with 10+ years of cross-disciplinary expertise spanning bioprocess development, analytical method validation, regulatory compliance, and biologics innovation. PhD candidate in Biotechnology (submission Oct 2026) integrating computational biology, multi-omics analysis, and machine learning with deep wet-laboratory expertise. Proven record of scaling complex biologics processes including lentiviral vectors (LVV) and adeno-associated virus (AAV) platforms for Cell & Gene Therapy (CAR-T), alongside large-scale vaccine development (COVID-19, PCV, MCV, Hepatitis-B, HIB, DPT, Pentavalent). Seasoned regulatory scientist with successful audit engagements across WHO, US-FDA, EU-GMP, TGA, ANVISA, CDSCO, and S-FDA frameworks. Executed international technology transfer across 8 countries (Germany, Russia, Egypt, Malaysia, Saudi Arabia, Iran, Cuba, China). BIRAC E-YUVA invited speaker and BioNEST bioprocessing trainer, uniquely positioned to translate deep scientific research into commercially viable, patent-grade innovations.
Name: Shrish Chandra Pandey
Education: M.Tech, PhD Biotechnology
PhD Status: Pursuing (Oct 2026)
Experience: 10+ Years
Phone: +91-9140087639
Email: shrish151092@gmail.com
Location: Delhi, India
Consulting: Available
Quality
Education & Experience
My Education
*PhD — Biotechnology (Pursuing)
Integral University, Lucknow | Jul 2023 - Oct 2026
Research focus: Identification of small molecule potential inhibitor against oncogenic Protein. Multi-omics data integration, cancer genomics, and ML-driven biomarker discovery.
Master's Degree (M. Tech), Biotechnology (with Honours)
Institute of Engineering and Technology (AKTU, Lucknow) | Jul 2017 - Oct 2019
Thesis: Purification and characterization of anti-tubercular compounds from Coriandrum-Sativum and its mode of action.
Bachelor's Degree (B. Tech), Bioengineering (with Honours)
Integral University, Lucknow, Uttar Pradesh | 2011 - 2015
Dissertation: Antibiotic Assay Validation (Bleomycin for Injection)
My Experience
CellXen Innovations LLP
Co-Founder & CTO | In Progress
Developing Hygro-Responsive Plant Extracellular Vesicles (HR-PEV) — a climate-adaptive, plant-derived nanocarrier platform for cosmetic actives. Patent-first model targeting BIRAC BIG grant and BioNEST incubation.
Invigorate Biotechnologies LLP, PBTI - Mohali, Punjab
Manager, Process Development (R&D) | Feb 2023 - May 2026
Cell & Gene Therapy scale-up (LVV production to 2-cell stack, 10⁹-10¹⁰ TU/ml), PEI transfection reagent formulation, AAV/LVV platform leadership for CAR-T therapy.
BioBridge Healthcare Solutions Pvt. Ltd. - Chandigarh
Senior Executive, Quality Control (R&D) | Jul 2021 - Feb 2023
Vaccine analytical development (SARS-CoV-2 S1 and N proteins, Bivalent COVID-19). Multi-vaccine platform R&D (Hepatitis-B, PCV, MCV, Meningococcal, DPT/Pentavalent). International technology transfer to Russia, Iran, Turkey, Egypt.
BioGlobe Research & Solutions LLP - Delhi
Technical Officer - Biotechnology | Jul 2019 - Jul 2021
Cell biology platforms (tissue culture, primary human cells, iPSC culturing and transfection). Assay development (ELISA, Flow Cytometry, SDS-PAGE, Western Blot, advanced imaging).
Venus Remedies Limited - Baddi (H.P.) & Panchkula (Haryana)
Asst. Manager / Executive Microbiologist / Management Trainee (QC) | May 2015 - Apr 2017
Regulatory audit success (EU-GMP, GLP, S-FDA, TGA, WHO). Microbiology & compliance (sterility analysis, bacterial endotoxin testing). Analytical QC (antibiotic and chromogenic assays, trend analysis).
Expertise
Core Expertise
Bioprocess Development & Scale-up
Expert in LVV/AAV process development for Cell & Gene Therapy (CAR-T), vaccine manufacturing (upstream & downstream), PEI transfection reagent formulation, and GMP-grade biologics manufacturing including vaccines, polysaccharides, and conjugates.
Analytical Methods & Validation
Specialized in ELISA, SDS-PAGE, Western Blot, Sec-HPLC, Flow Cytometry, Bacterial Endotoxin Testing, Sterility Analysis, Antibiotic & chromogenic assays, and protein/sugar content estimation for vaccines and biologics.
International Technology Transfer
Successfully executed end-to-end technology transfer of vaccines and analytical platforms to 8 countries: Germany, Russia, Egypt, Malaysia, Saudi Arabia, Iran, Cuba, and China, with comprehensive GMP & QMS training delivery.
Regulatory Compliance & Audits
Clean audit track record across WHO, US-FDA, EU-GMP, TGA, ANVISA, CDSCO, S-FDA, and GLP frameworks. IQ/OQ/PQ equipment qualification, SOP/STP validation, Quality Management Systems design, EUA, GRPs, and Pharmacovigilance expertise.
Computational Biology & Bioinformatics
Multi-omics data integration (genomics, transcriptomics, proteomics), cancer biomarker discovery using machine learning, bioinformatics pipeline development, in-silico assay design, and infectious disease modeling.
Cell Biology & Immunology
Mammalian cell culture, iPSC culturing & transfection, primary human cell work, tissue culture, FACS, and cellular/biochemical assay development for research and therapeutic applications.
Certification
Certifications
Successfully Organized Two Days Training program on "The Basics of Bioprocessing: Upstream & Downstream" @BioNEST Bio Incubator Regional Centre for Biotechnology
Two days Indo-US International Conference on Antimicrobial Resistance and Human Microbiome (ARHM 2023) @Translational Health Science Technology Institute, Faridabad
Three Days Workshop on Statistics in Clinical Trials organized by CDSA & DBT @Translational Health Science Technology Institute, Faridabad
One Day Symposium on Proteomics in Biotechnology and Biomedical Science Organized by BRICS @Translational Health Science Technology Institute, Faridabad
Successfully Completed One Week Online Faculty Development Programme on "Advanced Research Trends of Satellite Image Processing in Land Surface Monitoring" organized by Advanced Computing Research Lab HRDC @Integral University, Lucknow
2nd International Webinar Series on topic "Understanding Stress Response Adaptation in Adherent Invasive Escherichia coli" delivered by CIRB, College de France, Paris, France organized by IMS Ghaziabad
Review
Clients Say
Collaborating with Shrish has been an exceptional experience, marked by innovation, strategic clarity, and scientific excellence. He stands out as a uniquely skilled professional who brings deep technical expertise and visionary thinking to the healthcare and biopharmaceutical landscape. With a robust foundation in pharmaceutical sciences, translational medicine, and advanced therapeutic platforms, particularly Cell and Gene Therapy, Shrish has consistently delivered at the intersection of science and business. He demonstrates a remarkable ability to lead complex scientific initiatives, coordinate cross-functional teams, and drive progress across R&D, regulatory pathways, and commercial strategy.
Jainendra Jain
Founder & Director @ Invigorate Biotechnologies
Services
Freelance Services
Select Sector
Ready to Transform Your Operations?
Leverage 10+ years of cross-disciplinary expertise in bioprocess development, regulatory compliance, and technical implementation across Cell & Gene Therapy, Vaccines, Pharmaceuticals, and Cosmeceuticals.
Blog
Latest Articles
Lentiviral Vector Production for CAR-T Cell Therapy: Scale-up Strategies
Practical insights into scaling LVV production to clinical-grade specifications (10⁹-10¹⁰ TU/ml) for CAR-T immunotherapy.
Cost-Effective PEI Transfection Reagent Formulation for Gene Therapy
Developing novel, cost-effective PEI-based transfection reagents while maintaining batch-to-batch consistency.
Multi-Omics Data Integration for Cancer Biomarker Discovery
Leveraging genomics, transcriptomics, and proteomics with machine learning for oncology applications.
International Technology Transfer: 8-Country Success Stories
Lessons learned from executing successful technology transfer across Germany, Russia, Egypt, Malaysia, Saudi Arabia, Iran, Cuba, and China.
COVID-19 to Novel Vaccines: Scaling Biologics for Public Health
From Bivalent COVID-19 to PCV, MCV, Hepatitis-B, and Pentavalent vaccines: strategies for process development and GMP compliance.
WHO, FDA, EU-GMP Regulatory Audits: Audit-Ready Strategy
Comprehensive audit preparation strategies with clean track record across multiple regulatory frameworks.
iPSC Culture & Transfection Protocols for Cell Therapy Research
Advanced techniques for induced pluripotent stem cell culturing and high-efficiency transfection workflows.
AAV Platform Development: From Lab to Clinical Grade
Process development and analytical method validation for adeno-associated virus platforms used in gene therapy.